Risk factors

Braemar is exploring strategic alternatives like selling assets or the company, creating significant stock volatility and distraction. Total debt decreased slightly to $1.1 billion with $1.0 billion variable. Conflicts of interest and tax compliance remain major operational risks.

BJ's Wholesale Club added foreign sourcing and anti-takeover risks, updated e-commerce technology disclosures to include artificial intelligence, and reported digital sales growth.

The company added a risk regarding its $5 million share repurchase program and updated its credit facility and tariff exposures.

International trade policies and new tariffs pose operational threats to global supply chains.

The company added risks concerning thin stock trading, AI deployment, and 2024 private placement dilution. Commercial real estate loan concentration increased to 44.9% of total loans. Dividend suspensions and regulatory constraints continue.

Candel Therapeutics added financial and intellectual property covenants tied to the new RTW Purchase Agreement. The company updated drug candidate names from CAN-2409 and CAN-3110 to aglatimagene and linoserpaturev. New risks address banking sector instability, privacy laws, and patent enforcement changes.

CareCloud faces heightened operational risks regarding its 3,300 offshore employees in Pakistan and Sri Lanka.

International direct premiums decreased from approximately 67% to 64% of total direct premiums. New risks highlight exposures to mature endowment surrenders, long-duration contract accounting changes, and macroeconomic volatility.

Artificial intelligence is now a stated risk for CICB and its portfolio companies, including confidentiality, cybersecurity, intellectual-property and compliance exposures.

Nasdaq listing and delisting risks now dominate, with separate equity and bid-price compliance deadlines extending into 2026.

Community banking operations are concentrated in South Carolina and Georgia, exposing the company to regional real estate and economic downturns.

Corvus secured $189.4 million in a January 2026 offering, extending operations into the second quarter of 2028.